Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

A Bayesian network model for personalised COVID19 risk assessment and contact tracing

View ORCID ProfileNorman E Fenton, Scott McLachlan, Peter Lucas, Kudakwashe Dube, Graham A Hitman, Magda Osman, Evangelia Kyrimi, Martin Neil
doi: https://doi.org/10.1101/2020.07.15.20154286
Norman E Fenton
1Risk and Information Management, Queen Mary University of London, United Kingdom
7Agena Ltd, Cambridge, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Norman E Fenton
  • For correspondence: n.fenton@qmul.ac.uk
Scott McLachlan
1Risk and Information Management, Queen Mary University of London, United Kingdom
2Health informatics and Knowledge Engineering Research (HiKER) Group
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Lucas
3Faculty of EEMCS, University of Twente, Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kudakwashe Dube
2Health informatics and Knowledge Engineering Research (HiKER) Group
4School of Fundamental Sciences, Massey University, New Zealand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Graham A Hitman
5Centre for Genomics and Child Health, Blizard Institute, Queen Mary University of London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Magda Osman
6Biological and Experimental Psychology Group, Queen Mary University of London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Evangelia Kyrimi
1Risk and Information Management, Queen Mary University of London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martin Neil
1Risk and Information Management, Queen Mary University of London, United Kingdom
7Agena Ltd, Cambridge, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Concerns about the practicality and effectiveness of using Contact Tracing Apps (CTA) to reduce the spread of COVID19 have been well documented and, in the UK, led to the abandonment of the NHS CTA shortly after its release in May 2020. We present a causal probabilistic model (a Bayesian network) that provides the basis for a practical CTA solution that addresses some of the concerns and which has the advantage of minimal infringement of privacy. Users of the model can provide as much or little personal information as they wish about relevant risk factors, symptoms, and recent social interactions. The model then provides them feedback about the likelihood of the presence of asymptotic, mild or severe COVID19 (past, present and projected). When the model is embedded in a smartphone app, it can be used to detect new outbreaks in a monitored population and identify outbreak locations as early as possible. For this purpose, the only data needed to be centrally collected is the probability the user has COVID19 and the GPS location.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

The authors acknowledge support from the EPSRC under project EP/P009964/1: PAMBAYESIAN: Patient Managed decision-support using Bayesian Networks and The Alan Turing Institute under the EPSRC grant EP/N510129/1. We also acknowledge the support of Agena.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

NA

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Because the model and its web/phone implementation have been regularly updated, this paper does NOT describe the latest version.

    The latest version of the Bayesian network model can be downloaded from: http://www.eecs.qmul.ac.uk/~norman/Models/covid19_for_web.cmpx The model can be run using the free trial version of AgenaRisk (www.agenarisk.com)

    The model can also be run through a simple questionnaire interface over the web or on a mobile phone at https://covid19.apps.agenarisk.com/

  • Improvements made to the paper following reviewers' comments. The model has also been updated and improved with links provided to the latest version and its web implementation

  • 3 The model described in the section is NOT the latest version. The latest version can be downloaded from: http://www.eecs.qmul.ac.uk/~norman/Models/covid19_for_web.cmpx and can be run using the free trial version of AgenaRisk (www.agenarisk.com)

  • 8 Some of the limitations of the BN model described in this paper have been addressed in the latest version which can be downloaded from: http://www.eecs.qmul.ac.uk/~norman/Models/covid19_for_web.cmpx and run using the free trial version of AgenaRisk (www.agenarisk.com) The latest version of the model can also be run through a simple questionnaire interface over the web or on a mobile phone at https://covid19.apps.agenarisk.com/

Data Availability

Links are provided in the article to data and model

http://www.eecs.qmul.ac.uk/~norman/Models/covid19_for_contact_tracing_paper.cmpx

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted January 05, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
A Bayesian network model for personalised COVID19 risk assessment and contact tracing
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
A Bayesian network model for personalised COVID19 risk assessment and contact tracing
Norman E Fenton, Scott McLachlan, Peter Lucas, Kudakwashe Dube, Graham A Hitman, Magda Osman, Evangelia Kyrimi, Martin Neil
medRxiv 2020.07.15.20154286; doi: https://doi.org/10.1101/2020.07.15.20154286
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
A Bayesian network model for personalised COVID19 risk assessment and contact tracing
Norman E Fenton, Scott McLachlan, Peter Lucas, Kudakwashe Dube, Graham A Hitman, Magda Osman, Evangelia Kyrimi, Martin Neil
medRxiv 2020.07.15.20154286; doi: https://doi.org/10.1101/2020.07.15.20154286

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Health Informatics
Subject Areas
All Articles
  • Addiction Medicine (62)
  • Allergy and Immunology (144)
  • Anesthesia (47)
  • Cardiovascular Medicine (419)
  • Dentistry and Oral Medicine (72)
  • Dermatology (49)
  • Emergency Medicine (147)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (174)
  • Epidemiology (4906)
  • Forensic Medicine (3)
  • Gastroenterology (185)
  • Genetic and Genomic Medicine (689)
  • Geriatric Medicine (72)
  • Health Economics (193)
  • Health Informatics (636)
  • Health Policy (322)
  • Health Systems and Quality Improvement (209)
  • Hematology (86)
  • HIV/AIDS (157)
  • Infectious Diseases (except HIV/AIDS) (5408)
  • Intensive Care and Critical Care Medicine (333)
  • Medical Education (96)
  • Medical Ethics (24)
  • Nephrology (77)
  • Neurology (692)
  • Nursing (42)
  • Nutrition (115)
  • Obstetrics and Gynecology (128)
  • Occupational and Environmental Health (211)
  • Oncology (447)
  • Ophthalmology (140)
  • Orthopedics (36)
  • Otolaryngology (91)
  • Pain Medicine (37)
  • Palliative Medicine (18)
  • Pathology (131)
  • Pediatrics (201)
  • Pharmacology and Therapeutics (131)
  • Primary Care Research (88)
  • Psychiatry and Clinical Psychology (787)
  • Public and Global Health (1832)
  • Radiology and Imaging (328)
  • Rehabilitation Medicine and Physical Therapy (142)
  • Respiratory Medicine (257)
  • Rheumatology (87)
  • Sexual and Reproductive Health (69)
  • Sports Medicine (63)
  • Surgery (102)
  • Toxicology (23)
  • Transplantation (29)
  • Urology (38)